Christensen N J, Bygdeman M, Greén K, Jonasson H, Rundgren M, Wallin C J, Vesterqvist O, Leksell L G
Pflugers Arch. 1984 Dec;402(4):360-3. doi: 10.1007/BF00583936.
The effects of intravenous infusions of the stable prostaglandin analogue 9-deoxo-16,16-dimethyl-9-methylene-PGE2 (9-methylene-PGE2) in a dosage of 10 or 24 micrograms/min were studied in the consicious euhydrated, dehydrated, and hyperhydrated with the simultaneous administration of exogenous arginine vasopressin (AVP), sheep. The infusions decreased urine osmolality and increased urine flow and renal free water clearance. The results indicate that 9-methylene-PGE2 exhibits its diuretic effect by antagonizing the antidiuretic action of AVP. In the hyperhydrated sheep receiving AVP the syndrome of inappropriate antidiuretic hormone release (SIADH) was simulated. As the prostaglandin analogue effectively blocked the antidiuretic effect of the AVP-administration it appears that 9-methylene-PGE2 may play a future role as a diuretic agent, especially in conditions characterized by water retention and dilutional hyponatremia such as SIADH.
在清醒的、处于正常水合状态、脱水状态和水合过多状态的绵羊中,同时给予外源性精氨酸加压素(AVP),研究了以每分钟10或24微克的剂量静脉输注稳定的前列腺素类似物9-脱氧-16,16-二甲基-9-亚甲基-PGE2(9-亚甲基-PGE2)的效果。输注降低了尿渗透压,增加了尿流量和肾游离水清除率。结果表明,9-亚甲基-PGE2通过拮抗AVP的抗利尿作用发挥其利尿作用。在接受AVP的水合过多的绵羊中模拟了抗利尿激素分泌不当综合征(SIADH)。由于前列腺素类似物有效地阻断了AVP给药的抗利尿作用,因此9-亚甲基-PGE2似乎可能在未来作为一种利尿剂发挥作用,特别是在以水潴留和稀释性低钠血症为特征的疾病如SIADH中。